Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000649269 | SCV000771094 | benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-17 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000729933 | SCV000857635 | likely benign | not specified | 2017-10-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001595030 | SCV001829442 | benign | not provided | 2021-04-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002360634 | SCV002665170 | benign | Cardiovascular phenotype | 2019-03-28 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |